您的位置: 首页 > 农业专利 > 详情页

groundbreaking indansulfamide derivative
专利权人:
LTD.;EISAI R&D MANAGEMENT CO.
发明人:
HIROYUKI HIGASHIYAMA,Keiichi Sorimachi,MINAKO SAITO,TAKAHISA HANADA,TAKASHI KOSASA,TETSUYUKI TERAMOTO,TORU WATANABE,Toshiaki Tanaka,YOICHI KITA,YUKIO ISHIKAWA,Yuji Kazuta
申请号:
BR112014031565
公开号:
BR112014031565A2
申请日:
2013.06.17
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
summary "novel indansulfamide derivative" is an innovative indanesulfamide compound such as n - [(1s) -2,2,5,7-tetrafluoro-2,3-dihydro-1h-inden-1-yl] sulfamide, n- [(1s) -2,2,4,7-tetrafluoro-2,3-dihydro-1h-inden-1-yl] sulfamide, (+) - n- (2,2,4,6,7-pentafluoro- 2,3-dihydro-1h-inden-1-yl) sulfamide, or a pharmaceutically acceptable salt thereof has an effect of enhancing the severity (scoring) of an attack in a mouse kindling model and therefore one can expect it to serve as a therapeutic agent for epilepsy.resumo “derivado de indanossulfamida inovador” um composto de indanossulfamida inovador, tal como n-[(1s)-2,2,5,7-tetrafluoro-2,3-diidro-1h-inden-1-il]sulfamida, n-[(1s)-2,2,4,7-tetrafluoro-2,3-diidro-1h-inden-1-il]sulfamida, (+)-n- (2,2,4,6,7-pentafluoro-2,3-diidro-1h-inden-1-il)sulfamida, ou um sal farmaceuticamente aceitável dos mesmos tem um efeito de aprimorar a severidade (pontuação) de um ataque em um modelo de kindling de camundongos e, portanto, pode-se esperar que sirva como agente terapêutico para epilepsia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充